Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01679457 · ClinicalTrials.gov registry record · NA

Assessing Models of Exposure Therapy

A NA study, sponsored by Mclean Hospital.

Completed
Registry status
NA
Development phase
29
Enrollment target

NCT01679457 is a NA study that has completed, run by Mclean Hospital. The registered enrollment target is 29 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01679457, a NA study, has completed, sponsored by Mclean Hospital.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

The objective of this study is to learn how to improve treatment for clients who are working hard in treatment at the McLean Hospital Obsessive Compulsive Disorder Institute (OCDI), but who are not making the progress that would typically be expected. Therefore, the investigators will be comparing the performance of such clients in a treatment as usual (TAU)-Exposure and Response Prevention (ERP) session with their performance in an Acceptance and Commitment Therapy (ACT)-focused ERP session that follows an ACT booster session. The investigators hypothesize that clients will perform significantly better in the ACT-focused ERP session than they will in the TAU-ERP session. More specifically, the investigators hypothesize that clients and an independent rater will report that in the ACT-focused ERP session, clients performed significantly fewer rituals and/or avoidance behaviors, experienced comparable levels of distress, exerted significantly more effort, had significantly less difficulty getting started with the ERP, were significantly less influenced by their uncomfortable thoughts/feelings, were significantly more willing to experience discomfort, were significantly more focused on working towards what is important to the client. The investigators also hypothesize that an independent rater will rate clients as significantly more compliant with the ACT-focused ERP session than with the TAU-ERP session. The investigators also hypothesize that clients will rate the ACT-focused ERP session as significantly more preferable and acceptable than the TAU-ERP session, and that they will report being significantly more willing to do the ACT-focused ERP session again.

Interventions

  • BEHAVIORAL ACT-Focused ERP
  • BEHAVIORAL TAU-ERP

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2012-09
Est. Completion 2019-08
Phase NA

Sponsor

Mclean Hospital

140 total trials

What the Registry Record Tells You About NCT01679457

The ClinicalTrials.gov registry entry for NCT01679457 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which ACT-Focused ERP is the first listed.

NCT01679457 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01679457 about?

NCT01679457 is a clinical study titled "Assessing Models of Exposure Therapy". The objective of this study is to learn how to improve treatment for clients who are working hard in treatment at the McLean Hospital Obsessive Compulsive Disorder Institute (OCDI), but who are not making the progress that would typically be expected. Therefore, the investigators will be comparing t...

What is the current status of trial NCT01679457?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2012-09. Estimated completion is 2019-08.

What interventions are being tested in trial NCT01679457?

The interventions under investigation include: ACT-Focused ERP (BEHAVIORAL), TAU-ERP (BEHAVIORAL).

Who is sponsoring clinical trial NCT01679457?

This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.